Zeng Qiang, Luo YiTing, Fang Junxu, Xu Shuang, Hu Yuan-Hua, Yin Ming
Department of Ophthalmology, Yiwu Central Hospital, Yiwu, Zhejiang, China.
Department of Ophthalmology, 521 Hospital of Norinco Group, Xi'an, Shaanxi, China.
Eur J Ophthalmol. 2022 May;32(3):1584-1595. doi: 10.1177/11206721211020200. Epub 2021 Jun 7.
Diabetic retinopathy (DR), a common complication of diabetes mellitus, is the major cause of visual impairment and blindness. Circ_0000615 was found to be elevated in retina samples of diabetic patients. Hence, the detailed effects and molecular mechanisms of circ_0000615 in DN progression were explored.
The levels of circ_0000615, microRNA (miR)-646 and YAP1 (yes-associated protein 1) were detected using quantitative real-time polymerase chain reaction and Western blot assays. Cell viability, apoptosis, inflammation and reactive oxygen species (ROS) generation were determined using cell counting kit-8 assay, flow cytometry, caspase3 activity analysis, Western blot, enzyme-linked immunosorbent assay (ELISA) and Dichlorofluorescein diacetate (DCFH-DA) assay, respectively. The binding interaction between miR-646 and circ_0000615 or YAP1 was determined using dual-luciferase reporter, RNA immunoprecipitation (RIP), and RNA pull-down assays.
Circ_0000615 was elevated in high glucose (HG)-induced human retinal pigment epithelium (HRPE) cells. Knockdown of circ_0000615 attenuated HG-triggered HRPE cell apoptosis, inflammation, and ROS generation. Mechanistically, miR-646 was confirmed to be a target of circ_0000615, inhibition of miR-646 reversed the protective effects of circ_0000615 knockdown on HG-evoked HRPE cell dysfunction. MiR-646 was verified to target YAP1, overexpression of YAP1 abolished the impairment induced by miR-646 on HG-induced HRPE cell damage. Besides that, we confirmed that circ_0000615 could regulate YAP1 expression via miR-646.
Circ_0000615 contributed to HG-induced HRPE cell dysfunction via miR-646/YAP1 axis, suggesting a novel insight into the pathogenesis of DR and a potential candidate for DR treatment.
糖尿病视网膜病变(DR)是糖尿病常见的并发症,是视力损害和失明的主要原因。研究发现,糖尿病患者视网膜样本中circ_0000615水平升高。因此,本研究探讨了circ_0000615在糖尿病视网膜病变进展中的具体作用及分子机制。
采用定量实时聚合酶链反应和蛋白质免疫印迹法检测circ_0000615、微小RNA(miR)-646和YAP1(Yes相关蛋白1)的水平。分别采用细胞计数试剂盒-8法、流式细胞术、caspase3活性分析、蛋白质免疫印迹法、酶联免疫吸附测定(ELISA)和二氯荧光素二乙酸酯(DCFH-DA)法检测细胞活力、凋亡、炎症反应和活性氧(ROS)生成。采用双荧光素酶报告基因、RNA免疫沉淀(RIP)和RNA下拉实验确定miR-646与circ_0000615或YAP1之间的结合相互作用。
高糖(HG)诱导的人视网膜色素上皮(HRPE)细胞中circ_0000615水平升高。敲低circ_0000615可减轻HG诱导的HRPE细胞凋亡、炎症反应和ROS生成。机制上,miR-646被证实为circ_0000615的靶标,抑制miR-646可逆转circ_0000615敲低对HG诱导的HRPE细胞功能障碍的保护作用。miR-646被证实靶向YAP1,YAP1过表达可消除miR-646对HG诱导的HRPE细胞损伤的抑制作用。此外,我们证实circ_0000615可通过miR-646调节YAP1表达。
Circ_0000615通过miR-646/YAP1轴导致HG诱导的HRPE细胞功能障碍,为糖尿病视网膜病变的发病机制提供了新的见解,并为糖尿病视网膜病变的治疗提供了潜在的候选靶点。